[EN] THIENOPYRIDINE-PHENYLACET AMIDES AND THEIR DERIVATIVES USEFUL AS NEW ANTI-ANGIOGENIC AGENTS [FR] THIENOPYRIDINE-PHENYLACETAMIDES ET LEURS DERIVES UTILES COMME NOUVEAUX AGENTS ANTI-ANGIOGENIQUES
A new and highly efficient enzymatic aminolysis approach for kinetic resolution of aromatic α-hydroxy acid in non-aqueous media has been developed. The corresponding α-hydroxyl acid ester was employed as the substrate, and commercially available Candida antarctica lipase B is used as the biocatalyst, anhydrous ammonia is the resolving agent. Reactions can be proceeded smoothly in organic solvent at
The oxidation of arylacetic acids by peroxydisulphate in acetic acid media in the presence of potassium and coppe-(II) acetates leads to the corresponding benzylacetates. The mechanism of the reaction is rationalized by the occurence of two pathways: the intermediate formation of aromatic radical cations or the direct decarboxylation of the arylacetate ion. The importance of acetic acid as a rection
Thienopyridine-phenylacetamides and their derivatives useful as new anti-angiogenic agents
申请人:Lou Jihong
公开号:US20050090509A1
公开(公告)日:2005-04-28
The invention relates to compounds represented by Formula (I):
and to prodrugs thereof, pharmaceutically acceptable salts or solvates of said compounds or said prodrugs, wherein each of X
1
-X
5
and R
1
-R
5
are defined herein. The invention also relates to pharmaceutical compositions containing the compounds of Formula (I) and to methods of treating hyperproliferative disorders in a mammal by administering compounds of Formula (I).